Zhuqing Liu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CTMP-REV7 axis modulates MHC-I antigen presentation via CDK1-AKT crosstalk in MSI-L/MSS colorectal cancer.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: March 18, 2026
Predictive factors and outcomes of immune-related adverse events in Chinese patients treated with immune checkpoint inhibitors: a real-world retrospective study.
Journal: Frontiers in immunology
Published: June 28, 2025
Anti-PD-1 Nanobody-Armored MSLN CAR-T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 21, 2025
Targeting crosstalk of STAT3 between tumor-associated M2 macrophages and Tregs in colorectal cancer.
Targeting crosstalk of STAT3 between tumor-associated M2 macrophages and Tregs in colorectal cancer.
Journal: Cancer biology & therapy
Published: June 29, 2023
Oncolytic adenovirus H101 ameliorate the efficacy of anti-PD-1 monotherapy in colorectal cancer.
Journal: Cancer medicine
Published: October 03, 2021
The upregulation of PYCR2 is associated with aggressive colon cancer progression and a poor prognosis.
Journal: Biochemical and biophysical research communications
Published: July 04, 2021
Novel Effector Phenotype of Tim-3+ Regulatory T Cells Leads to Enhanced Suppressive Function in Head and Neck Cancer Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 10, 2017
Last Updated: 09/26/2026